NCT07005024 2026-02-05
DOAC
University of Vermont
Phase 3 Recruiting
Clinical Trials
10 trialsNCT06603870 2025-05-30
STREAM-Line
Ottawa Hospital Research Institute
Phase 4 Recruiting
NCT03692065 2025-02-06
API-CAT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT01999179 2022-05-18
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
Phase NA Completed
NCT02585713 2020-08-04
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Phase 3 Completed
NCT04462003 2020-07-08
DVT
Beni-Suef University
Phase 3 Unknown
NCT02048865 2018-11-20
AVERT
Ottawa Hospital Research Institute
Phase 2 Completed
NCT02581176 2018-06-26
CAP
University Hospital, Akershus
Phase 4 Completed
NCT00320255 2016-08-16
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
Bristol-Myers Squibb
Phase 2 Completed